CN Stock MarketDetailed Quotes

600479 Zhuzhou Qianjin Pharmaceutical

Watchlist
  • 9.19
  • +0.02+0.22%
Market Closed Sep 11 15:00 CST
3.90BMarket Cap12.12P/E (TTM)

Zhuzhou Qianjin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
0.60%1.92B
4.22%1B
-5.66%3.8B
-4.01%2.78B
0.11%1.91B
0.78%960.2M
9.89%4.03B
8.50%2.89B
8.94%1.91B
4.44%952.8M
Operating revenue
0.60%1.92B
4.22%1B
-5.66%3.8B
-4.01%2.78B
0.11%1.91B
0.78%960.2M
9.89%4.03B
8.50%2.89B
8.94%1.91B
4.44%952.8M
Other operating revenue
-7.24%36.63M
----
8.46%77.38M
----
16.17%39.48M
----
9.56%71.35M
----
3.54%33.99M
----
Total operating cost
-0.21%1.74B
3.11%921.11M
-7.15%3.36B
-5.24%2.5B
-0.50%1.75B
0.74%893.3M
9.47%3.61B
8.34%2.64B
8.22%1.76B
4.29%886.78M
Operating cost
0.35%1.06B
1.53%543M
-10.62%2.05B
-7.68%1.5B
-1.07%1.05B
0.09%534.83M
12.68%2.29B
12.09%1.62B
12.91%1.06B
10.49%534.36M
Operating tax surcharges
2.28%19.32M
7.89%10.3M
0.19%38M
2.88%28.18M
3.68%18.89M
-1.34%9.55M
8.03%37.93M
3.05%27.39M
6.71%18.22M
10.41%9.68M
Operating expense
-12.76%438.69M
-7.39%248.84M
-0.80%904.27M
-4.25%701.81M
-0.04%502.82M
0.73%268.7M
2.62%911.58M
1.53%732.95M
-0.23%503.04M
-5.29%266.75M
Administration expense
-2.48%123.36M
8.51%59.82M
-0.46%263.58M
11.70%196.72M
5.22%126.5M
12.37%55.13M
8.62%264.79M
7.01%176.11M
7.96%120.22M
-5.86%49.06M
Financial expense
45.10%-6.62M
-207.99%-1.31M
-1,264.38%-45.43M
-2,234.82%-34.52M
-1,192.02%-12.06M
-31.55%1.21M
45.58%-3.33M
82.14%-1.48M
111.49%1.1M
164.08%1.77M
-Interest expense (Financial expense)
-29.42%1.39M
-30.96%911.04K
-24.67%1.67M
22.81%2.25M
61.51%1.97M
74.66%1.32M
4.72%2.21M
11.72%1.83M
11.03%1.22M
-25.33%755.56K
-Interest Income (Financial expense)
33.46%-10.29M
-156.96%-4.81M
-426.78%-51.39M
-518.72%-38.95M
-386.90%-15.47M
-21.27%-1.87M
18.35%-9.76M
46.83%-6.29M
72.06%-3.18M
63.29%-1.54M
Research and development
89.07%114.75M
153.14%60.46M
30.97%149.07M
35.31%111.29M
17.52%60.69M
-5.09%23.88M
4.70%113.82M
-2.22%82.25M
-12.97%51.64M
-6.56%25.17M
Credit Impairment Loss
-34.75%-15.28M
9.11%-10.02M
-723.29%-18.27M
-22.07%-14.23M
-3.35%-11.34M
13.50%-11.03M
-305.68%-2.22M
-21.33%-11.65M
-11.72%-10.97M
-20.77%-12.75M
Asset Impairment Loss
611.71%833.77K
----
-102.47%-2.57M
---162.94K
---162.94K
----
9.50%-1.27M
--0
--0
--0
Other net revenue
-226.87%-5.75M
-898.79%-8.34M
-39.70%19.67M
-37.12%5M
-45.56%4.53M
86.11%-835.29K
-56.15%32.62M
-73.27%7.95M
-50.52%8.32M
7.51%-6.01M
Fair value change income
156.64%2.88M
177.55%990.33K
-23.12%-1.6M
-18.84%-3.96M
-467.72%-5.09M
-85.39%-1.28M
-127.48%-1.3M
-246.62%-3.33M
22.99%1.38M
-75.76%-688.83K
Invest income
-125.21%-2.92M
-157.76%-2.72M
-16.60%17.47M
-5.80%11.41M
14.66%11.6M
10.49%4.72M
-3.43%20.95M
-20.79%12.11M
23.87%10.12M
177.32%4.27M
-Including: Investment income associates
-369.32%-3.04M
-77.44%-2.72M
320.43%8.02M
105.87%588.47K
124.32%1.13M
-1,899.07%-1.54M
-1,185.90%-3.64M
-3,869.65%-10.02M
-468.27%-4.64M
125.36%85.36K
Asset deal income
----
----
----
--0
----
----
----
--0
--0
--0
Other revenue
-8.22%8.74M
-49.42%3.42M
49.67%24.64M
10.28%11.94M
22.19%9.52M
113.90%6.75M
11.38%16.46M
6.54%10.83M
36.39%7.79M
8.55%3.16M
Operating profit
2.87%173.89M
7.91%71.29M
3.98%461.94M
7.39%282.38M
4.33%169.03M
10.08%66.06M
1.84%444.25M
0.67%262.95M
10.14%162.02M
8.22%60.01M
Add:Non operating Income
50.65%804.82K
205.10%642.23K
-65.34%996.26K
-59.19%1.02M
-1.24%534.23K
-40.47%210.5K
44.09%2.87M
102.49%2.51M
-47.72%540.95K
119.74%353.58K
Less:Non operating expense
130.06%949.16K
84.93%402.26K
92.22%2.52M
-16.14%871.66K
-59.59%412.57K
-76.47%217.52K
-72.76%1.31M
-60.55%1.04M
-56.70%1.02M
-54.37%924.49K
Total profit
2.71%173.75M
8.29%71.52M
3.28%460.42M
6.85%282.53M
4.71%169.15M
11.12%66.05M
2.86%445.81M
1.77%264.42M
10.81%161.54M
10.92%59.44M
Less:Income tax cost
-0.59%24.68M
13.03%10.52M
11.48%65.4M
6.47%42.92M
8.66%24.82M
10.93%9.3M
-0.03%58.67M
4.47%40.31M
14.50%22.85M
6.81%8.39M
Net profit
3.28%149.07M
7.51%61.01M
2.03%395.02M
6.92%239.61M
4.06%144.33M
11.15%56.75M
3.31%387.15M
1.30%224.12M
10.23%138.69M
11.62%51.05M
Net profit from continuing operation
3.28%149.07M
7.51%61.01M
2.03%395.02M
6.92%239.61M
4.06%144.33M
11.15%56.75M
3.31%387.15M
1.30%224.12M
10.23%138.69M
11.62%51.05M
Less:Minority Profit
13.49%31.34M
15.33%14.81M
-11.85%74.61M
15.62%42.71M
15.34%27.62M
15.93%12.84M
16.46%84.64M
15.33%36.94M
7.44%23.94M
41.64%11.08M
Net profit of parent company owners
0.87%117.72M
5.22%46.2M
5.92%320.41M
5.20%196.91M
1.71%116.71M
9.83%43.91M
0.15%302.51M
-1.07%187.18M
10.83%114.75M
5.43%39.98M
Earning per share
Basic earning per share
2.21%0.2777
5.48%0.1077
7.32%0.7583
5.30%0.4586
1.76%0.2717
9.78%0.1021
-2.11%0.7066
-3.67%0.4355
7.92%0.267
2.65%0.093
Diluted earning per share
2.21%0.2777
5.48%0.1077
7.32%0.7583
5.30%0.4586
1.76%0.2717
9.78%0.1021
-2.11%0.7066
-3.67%0.4355
7.92%0.267
2.65%0.093
Other composite income
87.67%-246.99
-210.87%-246.99
-71.53%185.42K
-76.38%189.13K
-100.25%-2K
-94.67%222.77
21,290.59%651.29K
29,873.60%800.64K
41,849.95%800.64K
287.68%4.18K
Other composite income of parent company owners
87.67%-246.99
-210.87%-246.99
-71.53%185.42K
-76.38%189.13K
-100.25%-2K
-94.67%222.77
21,290.59%651.29K
29,873.60%800.64K
41,849.95%800.64K
287.68%4.18K
Total composite income
3.28%149.07M
7.51%61.01M
1.91%395.2M
6.62%239.8M
3.47%144.33M
11.14%56.75M
3.48%387.8M
1.66%224.92M
10.86%139.49M
11.63%51.06M
Total composite income of parent company owners
0.87%117.72M
5.22%46.2M
5.75%320.59M
4.85%197.1M
1.00%116.71M
9.82%43.91M
0.36%303.16M
-0.65%187.98M
11.60%115.55M
5.44%39.98M
Total composite income of minority owners
13.49%31.34M
15.33%14.81M
-11.85%74.61M
15.62%42.71M
15.34%27.62M
15.93%12.84M
16.46%84.64M
15.33%36.94M
7.44%23.94M
41.64%11.08M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Tianzhu International Accounting Firm (Special General Partnership)
--
--
--
Tianzhu International Accounting Firm (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 0.60%1.92B4.22%1B-5.66%3.8B-4.01%2.78B0.11%1.91B0.78%960.2M9.89%4.03B8.50%2.89B8.94%1.91B4.44%952.8M
Operating revenue 0.60%1.92B4.22%1B-5.66%3.8B-4.01%2.78B0.11%1.91B0.78%960.2M9.89%4.03B8.50%2.89B8.94%1.91B4.44%952.8M
Other operating revenue -7.24%36.63M----8.46%77.38M----16.17%39.48M----9.56%71.35M----3.54%33.99M----
Total operating cost -0.21%1.74B3.11%921.11M-7.15%3.36B-5.24%2.5B-0.50%1.75B0.74%893.3M9.47%3.61B8.34%2.64B8.22%1.76B4.29%886.78M
Operating cost 0.35%1.06B1.53%543M-10.62%2.05B-7.68%1.5B-1.07%1.05B0.09%534.83M12.68%2.29B12.09%1.62B12.91%1.06B10.49%534.36M
Operating tax surcharges 2.28%19.32M7.89%10.3M0.19%38M2.88%28.18M3.68%18.89M-1.34%9.55M8.03%37.93M3.05%27.39M6.71%18.22M10.41%9.68M
Operating expense -12.76%438.69M-7.39%248.84M-0.80%904.27M-4.25%701.81M-0.04%502.82M0.73%268.7M2.62%911.58M1.53%732.95M-0.23%503.04M-5.29%266.75M
Administration expense -2.48%123.36M8.51%59.82M-0.46%263.58M11.70%196.72M5.22%126.5M12.37%55.13M8.62%264.79M7.01%176.11M7.96%120.22M-5.86%49.06M
Financial expense 45.10%-6.62M-207.99%-1.31M-1,264.38%-45.43M-2,234.82%-34.52M-1,192.02%-12.06M-31.55%1.21M45.58%-3.33M82.14%-1.48M111.49%1.1M164.08%1.77M
-Interest expense (Financial expense) -29.42%1.39M-30.96%911.04K-24.67%1.67M22.81%2.25M61.51%1.97M74.66%1.32M4.72%2.21M11.72%1.83M11.03%1.22M-25.33%755.56K
-Interest Income (Financial expense) 33.46%-10.29M-156.96%-4.81M-426.78%-51.39M-518.72%-38.95M-386.90%-15.47M-21.27%-1.87M18.35%-9.76M46.83%-6.29M72.06%-3.18M63.29%-1.54M
Research and development 89.07%114.75M153.14%60.46M30.97%149.07M35.31%111.29M17.52%60.69M-5.09%23.88M4.70%113.82M-2.22%82.25M-12.97%51.64M-6.56%25.17M
Credit Impairment Loss -34.75%-15.28M9.11%-10.02M-723.29%-18.27M-22.07%-14.23M-3.35%-11.34M13.50%-11.03M-305.68%-2.22M-21.33%-11.65M-11.72%-10.97M-20.77%-12.75M
Asset Impairment Loss 611.71%833.77K-----102.47%-2.57M---162.94K---162.94K----9.50%-1.27M--0--0--0
Other net revenue -226.87%-5.75M-898.79%-8.34M-39.70%19.67M-37.12%5M-45.56%4.53M86.11%-835.29K-56.15%32.62M-73.27%7.95M-50.52%8.32M7.51%-6.01M
Fair value change income 156.64%2.88M177.55%990.33K-23.12%-1.6M-18.84%-3.96M-467.72%-5.09M-85.39%-1.28M-127.48%-1.3M-246.62%-3.33M22.99%1.38M-75.76%-688.83K
Invest income -125.21%-2.92M-157.76%-2.72M-16.60%17.47M-5.80%11.41M14.66%11.6M10.49%4.72M-3.43%20.95M-20.79%12.11M23.87%10.12M177.32%4.27M
-Including: Investment income associates -369.32%-3.04M-77.44%-2.72M320.43%8.02M105.87%588.47K124.32%1.13M-1,899.07%-1.54M-1,185.90%-3.64M-3,869.65%-10.02M-468.27%-4.64M125.36%85.36K
Asset deal income --------------0--------------0--0--0
Other revenue -8.22%8.74M-49.42%3.42M49.67%24.64M10.28%11.94M22.19%9.52M113.90%6.75M11.38%16.46M6.54%10.83M36.39%7.79M8.55%3.16M
Operating profit 2.87%173.89M7.91%71.29M3.98%461.94M7.39%282.38M4.33%169.03M10.08%66.06M1.84%444.25M0.67%262.95M10.14%162.02M8.22%60.01M
Add:Non operating Income 50.65%804.82K205.10%642.23K-65.34%996.26K-59.19%1.02M-1.24%534.23K-40.47%210.5K44.09%2.87M102.49%2.51M-47.72%540.95K119.74%353.58K
Less:Non operating expense 130.06%949.16K84.93%402.26K92.22%2.52M-16.14%871.66K-59.59%412.57K-76.47%217.52K-72.76%1.31M-60.55%1.04M-56.70%1.02M-54.37%924.49K
Total profit 2.71%173.75M8.29%71.52M3.28%460.42M6.85%282.53M4.71%169.15M11.12%66.05M2.86%445.81M1.77%264.42M10.81%161.54M10.92%59.44M
Less:Income tax cost -0.59%24.68M13.03%10.52M11.48%65.4M6.47%42.92M8.66%24.82M10.93%9.3M-0.03%58.67M4.47%40.31M14.50%22.85M6.81%8.39M
Net profit 3.28%149.07M7.51%61.01M2.03%395.02M6.92%239.61M4.06%144.33M11.15%56.75M3.31%387.15M1.30%224.12M10.23%138.69M11.62%51.05M
Net profit from continuing operation 3.28%149.07M7.51%61.01M2.03%395.02M6.92%239.61M4.06%144.33M11.15%56.75M3.31%387.15M1.30%224.12M10.23%138.69M11.62%51.05M
Less:Minority Profit 13.49%31.34M15.33%14.81M-11.85%74.61M15.62%42.71M15.34%27.62M15.93%12.84M16.46%84.64M15.33%36.94M7.44%23.94M41.64%11.08M
Net profit of parent company owners 0.87%117.72M5.22%46.2M5.92%320.41M5.20%196.91M1.71%116.71M9.83%43.91M0.15%302.51M-1.07%187.18M10.83%114.75M5.43%39.98M
Earning per share
Basic earning per share 2.21%0.27775.48%0.10777.32%0.75835.30%0.45861.76%0.27179.78%0.1021-2.11%0.7066-3.67%0.43557.92%0.2672.65%0.093
Diluted earning per share 2.21%0.27775.48%0.10777.32%0.75835.30%0.45861.76%0.27179.78%0.1021-2.11%0.7066-3.67%0.43557.92%0.2672.65%0.093
Other composite income 87.67%-246.99-210.87%-246.99-71.53%185.42K-76.38%189.13K-100.25%-2K-94.67%222.7721,290.59%651.29K29,873.60%800.64K41,849.95%800.64K287.68%4.18K
Other composite income of parent company owners 87.67%-246.99-210.87%-246.99-71.53%185.42K-76.38%189.13K-100.25%-2K-94.67%222.7721,290.59%651.29K29,873.60%800.64K41,849.95%800.64K287.68%4.18K
Total composite income 3.28%149.07M7.51%61.01M1.91%395.2M6.62%239.8M3.47%144.33M11.14%56.75M3.48%387.8M1.66%224.92M10.86%139.49M11.63%51.06M
Total composite income of parent company owners 0.87%117.72M5.22%46.2M5.75%320.59M4.85%197.1M1.00%116.71M9.82%43.91M0.36%303.16M-0.65%187.98M11.60%115.55M5.44%39.98M
Total composite income of minority owners 13.49%31.34M15.33%14.81M-11.85%74.61M15.62%42.71M15.34%27.62M15.93%12.84M16.46%84.64M15.33%36.94M7.44%23.94M41.64%11.08M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Tianzhu International Accounting Firm (Special General Partnership)------Tianzhu International Accounting Firm (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg